Roivant Sciences Ltd. (ROIV)
NASDAQ: ROIV · Real-Time Price · USD
39.03
-0.74 (-1.86%)
Sep 21, 2026, 3:21 PM EDT - Market open
Roivant Sciences Market Cap
Roivant Sciences has a market cap or net worth of $28.19 billion as of September 21, 2026. Its market cap has increased by 174.50% in one year.
Market Cap
28.19B
Enterprise Value
24.46B
1-Year Change
174.50%
Ranking
Category
Stock Price
$39.03
ChartMarket Cap Chart
Since December 8, 2020, Roivant Sciences's market cap has increased from $533.38M to $28.19B, an increase of 5,185.62%. That is a compound annual growth rate of 98.45%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 21, 2026 | 28.19B | 86.80% |
| Dec 31, 2025 | 15.09B | 75.25% |
| Dec 31, 2024 | 8.61B | -4.61% |
| Dec 29, 2023 | 9.03B | 55.76% |
| Dec 30, 2022 | 5.80B | -18.13% |
| Dec 31, 2021 | 7.08B | 1,257.32% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 8, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Revolution Medicines | 40.93B |
| BeOne Medicines AG | 39.89B |
| Royalty Pharma | 33.59B |
| Alnylam Pharmaceuticals | 32.06B |
| Insmed | 26.21B |
| Incyte | 25.40B |
| BioNTech SE | 24.13B |
| Genmab | 20.72B |